ABIVAX S.A. Earnings Dividend

ABIVAX S.A.’s revenue fell -127.26% since last year same period to $-2.02Mn in the Q4 2025. On a quarterly growth basis, ABIVAX S.A. has generated -Inf% fall in its revenue since last 3-months.

ABIVAX S.A.’s net profit fell -134.72% since last year same period to $-222.05Mn in the Q4 2025. On a quarterly growth basis, ABIVAX S.A. has generated -44.79% fall in its net profits since last 3-months.

ABIVAX S.A.’s net profit margin jumped 961.02% since last year same period to 11009.07% in the Q4 2025. On a quarterly growth basis, ABIVAX S.A. has generated NaN% jump in its net profit margins since last 3-months.

ABIVAX S.A.’s earning per share (EPS) estimates for the current quarter stand at -1.04 - a -31.65% fall from last quarter’s estimates.

ABIVAX S.A.’s earning per share (EPS) estimates for the current year stand at -1.04.

ABIVAX S.A.’s earning per share (EPS) fell -44.91% since last year same period to -1.18 in the Q4 2025. This indicates that the ABIVAX S.A. has generated -44.91% annual rate of fall in its earning per share (EPS) in the last 4 quarters.